Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

57.02
Delayed Data
As of 3:59pm ET
 -3.25 / -5.39%
Today’s Change
19.51
Today|||52-Week Range
73.72
-10.11%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$7.0B

Company Description

Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The firm's preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Contact Information

Arrowhead Pharmaceuticals, Inc.
177 East Colorado Boulevard
Pasadena California 91105
P:(626) 304-3400
Investor Relations:

Employees

Shareholders

Individual stakeholders5.26%
Mutual fund holders39.99%
Other institutional24.87%

Top Executives

Christopher Richard AnzalonePresident, Chief Executive Officer & Director
Kenneth Allen MyszkowskiChief Financial Officer
Javier San MartinChief Medical Officer
James C. HamiltonVice President & Head-Clinical Development
Jeff KetelhutVice President-Information Technology & Systems